Systemic HER3 ligand-mimicking nanobioparticles enter the brain and reduce intracranial tumour growth

By sjmartinez • February 22, 2025

Alonso-Valenteen F, Mikhael S, Wang H, Sims J, Taguiam M, Teh J, Sances S, Wong M, Miao T, Srinivas D, Gonzalez-Almeyda N, Cho RH, Sanchez R, Nguyenle K, Serrano E, Ondatje B, Benhaghnazar RL, Gray HB, Gross Z, Yu J, Svendsen CN, Abrol R, Medina-Kauwe LK. Systemic HER3 ligand-mimicking nanobioparticles enter the brain and reduce intracranial tumour growth. Nat Nanotechnol. 2025 Feb 21. doi: 10.1038/s41565-025-01867-7. Epub ahead of print. PMID: 39984637.

Tags: Cedars Sinai DoM, Infectious Diseases, Publications

Incidence and Risk Factors of De Novo Postpartum Hypertension: Understanding Links to Long-Term Cardiovascular Risk

Emeruwa UN, Çapi A, Jacobs MB, Laurent LC, Bello NA, Gyamfi-Bannerman C. Incidence and Risk Factors of De Novo Postpartum Hypertension: Understanding Links to Long-Term[...]

Outcomes of isolated tricuspid replacement versus repair among older patients with tricuspid regurgitation in the United States

Shimoda TM, Ueyama HA, Miyamoto Y, Watanabe A, Gotanda H, Elmariah S, Yokoyama Y, Fukuhara S, Kaneko T, Kuno T, Tsugawa Y. Outcomes of isolated[...]

Extracellular vesicle digital scoring assay for assessment of treatment responses in hepatocellular carcinoma patients

Zhao C, Lee YT, Melehy A, Kim M, Yang JZ, Zhang C, Kim J, Zhang RY, Lee J, Kim H, Ju Y, Tsai YJ, Zhou[...]